Bicycle Therapeutics Plc financial data

Symbol
BCYC on Nasdaq
Industry
Pharmaceutical Preparations
Location
Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
BICYCLE THERAPEUTICS Ltd (to 5/24/2019)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.05K % +49.8%
Debt-to-equity 40.7 % -39.3%
Return On Equity -32.8 % +40%
Return On Assets -23.3 % +28.8%
Operating Margin -463 % +29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30M shares +1.33%
Common Stock, Shares, Outstanding 68.9M shares +125%
Entity Public Float 767M USD +56.7%
Common Stock, Value, Issued 889K USD +124%
Weighted Average Number of Shares Outstanding, Basic 52M shares +72.2%
Weighted Average Number of Shares Outstanding, Diluted 52M shares +72.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 39.6M USD +75.7%
Research and Development Expense 159M USD +33.6%
General and Administrative Expense 63.5M USD +27%
Operating Income (Loss) -183M USD -24.9%
Nonoperating Income (Expense) 20.4M USD +300%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -163M USD -15%
Income Tax Expense (Benefit) 2.36M USD
Net Income (Loss) Attributable to Parent -165M USD -18.1%
Earnings Per Share, Basic -3.76 USD/shares +19.7%
Earnings Per Share, Diluted -3.76 USD/shares +19.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 961M USD +182%
Accounts Receivable, after Allowance for Credit Loss, Current 233K USD -99.5%
Assets, Current 1.03B USD +152%
Property, Plant and Equipment, Net 11.6M USD -34.1%
Operating Lease, Right-of-Use Asset 10.9M USD -31.8%
Other Assets, Noncurrent 6.58M USD -45.8%
Assets 1.06B USD +133%
Accounts Payable, Current 7.45M USD +42%
Employee-related Liabilities, Current 9.24M USD +29.5%
Accrued Liabilities, Current 28.1M USD -24.5%
Liabilities, Current 69.6M USD -3.67%
Operating Lease, Liability, Noncurrent 6.73M USD -43.4%
Other Liabilities, Noncurrent 4.7M USD +8.59%
Liabilities 184M USD -21.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.09M USD -24.5%
Retained Earnings (Accumulated Deficit) -578M USD -40.1%
Stockholders' Equity Attributable to Parent 874M USD +297%
Liabilities and Equity 1.06B USD +133%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -70.9M USD -52.7%
Net Cash Provided by (Used in) Financing Activities 1.87M USD -31.2%
Net Cash Provided by (Used in) Investing Activities -12K USD +99.4%
Common Stock, Shares Authorized 154M shares +159%
Common Stock, Shares, Issued 68.9M shares +125%
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -69.4M USD -53.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 962M USD +183%
Interest Paid, Excluding Capitalized Interest, Operating Activities 686K USD +1.03%
Deferred Tax Assets, Valuation Allowance 80.3M USD +49.4%
Deferred Tax Assets, Gross 88.6M USD +33.5%
Operating Lease, Liability 11.8M USD -28.6%
Depreciation 6.6M USD +11.9%
Payments to Acquire Property, Plant, and Equipment 12K USD -99.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -166M USD -17.9%
Lessee, Operating Lease, Liability, to be Paid 17.1M USD +358%
Property, Plant and Equipment, Gross 28.2M USD +0.64%
Operating Lease, Liability, Current 5.1M USD +8.93%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.84M USD -0.27%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.88M USD -50.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -767K USD +63.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.05M USD -49.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.34M USD -0.21%
Deferred Tax Assets, Operating Loss Carryforwards 66.6M USD +46.4%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 821K USD 0%
Operating Lease, Payments 1.44M USD +6.22%
Additional Paid in Capital 1.45B USD +129%
Depreciation, Depletion and Amortization 1.66M USD +6.49%
Share-based Payment Arrangement, Expense 33.8M USD +20.1%
Interest Expense 3.28M USD -1.74%